Concepedia

Author

Marco Vimercati

Medtronic (Italy)

Also Known As

M E Vimercati, M Vimercati, M. E. Vimercati, M. Vimercati, MARCO VIMERCATI, Marco Vimercati, Vimercati, Marco

32

Publications

1K

Citations

10

H-Index

18

Concepts

All Affiliations

Medtronic (Italy)Ospedale San Filippo NeriUniversity of FlorenceUniversity of BolognaIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
MV

About

Marco Vimercati is an author at Medtronic (Italy) specializing in cardiology, medicine, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

435

2

Engineering

1

1

17

3

Public Health

1

1

398

4

Emergency Medicine

1

1

398

5

Pharmacology

1

1

20

Marco Vimercati

×

10

Publications

991

Citations

10

H-Index

YearCitations

Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia Pacemakers

Alessandro Capucci, Massimo Santini, Luigi Padeletti,

Journal of the American College of Cardiology

2005

398

Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events

Giovanni Luca Botto, Luigi Padeletti, Massimo Santini,

Journal of Cardiovascular Electrophysiology

2008

378

New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial

Luigi Padeletti, Helmut Pürerfellner, Raymond Tukkie,

Heart Rhythm

2015

64

Improving Thromboprophylaxis Using Atrial Fibrillation Diagnostic Capabilities in Implantable Cardioverter-Defibrillators

Giuseppe Boriani, Massimo Santini, Maurizio Lunati,

Circulation Cardiovascular Quality and Outcomes

2012

33

Temporal variability of atrial tachyarrhythmia burden in bradycardia–tachycardia syndrome patients

Luigi Padeletti, Massimo Santini, Giuseppe Boriani,

European Heart Journal

2004

31

Predictors of Atrial Antitachycardia Pacing Efficacy in Patients Affected by Brady‐Tachy Form of Sick Sinus Syndrome and Implanted with a DDDRP Device

Giuseppe Boriani, Luigi Padeletti, Massimo Santini,

Journal of Cardiovascular Electrophysiology

2005

20

The Drug And Pace Health cliNical Evaluation (DAPHNE) study: A randomized trial comparing sotalol versus β-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker

Alessandro Capucci, Gianluca Botto, Giulio Molon,

American Heart Journal

2008

20

Intrathoracic and Ventricular Impedances are Associated with Changes in Ventricular Volume in Patients Receiving Defibrillators for CRT

Massimiliano Maines, Maurizio Landolina, Maurizio Lunati,

Pacing and Clinical Electrophysiology

2009

20

Implantable Loop Recorders: A Novel Method to Judge Patient Perception of Atrial Fibrillation. Preliminary Results from a Pilot Study

A. S. Montenero, Abdul Quayyum, Pasquale Franciosa,

Journal of Interventional Cardiac Electrophysiology

2004

17

Temporal Variability of Atrial Fibrillation in Pacemaker Recipients for Bradycardia: Implications for Crossover Designed Trials, Study Sample Size, and Identification of Responder Patients by Means of Arrhythmia Burden

Giovanni Luca Botto, Massimo Santini, Luigi Padeletti,

Journal of Cardiovascular Electrophysiology

2007

10

Page 1